Deal Intelligence That Reveals Opportunity.
Advisory That Delivers Results.
Supporting investors and operators across the global life sciences ecosystem.
Tulevik combines proprietary intelligence, advanced analytics, and deep industry connectivity to identify opportunities earlier, execute transactions more effectively, and expand strategically across complex life sciences markets.
Critical Decisions We Help Solve
Tulevik helps investors, strategics, and innovators answer four critical questions with clarity, conviction, and data-driven insight across life sciences strategy and transactions:
Identify the most attractive markets, technologies, and opportunity spaces across the life sciences.
Prioritize acquisition targets, partnerships, and investments that drive strategic value.
Assess market readiness and transaction conditions to act at the right moment
Execute transactions and market entry strategies with confidence and strategic clarity.
What we do
Tulevik supports the full strategic decision lifecycle — from identifying opportunities to executing transactions and scaling growth.
Deal intelligence
Services
Typical outcomes
Curated M&A advisory
Services
Typical outcomes
Insight-driven market entry
Services
Typical outcomes
The Tulevik difference
Unique intelligence, deep sector expertise, and trusted networks that uncover opportunities others miss.
Decades of experience advising investors and operators across life sciences, and the pharmaceutical value chain — combining strategic insight with real transaction experience.
A trusted network of executives, investors, and operators that unlocks opportunities and insights beyond traditional advisory channels.
Unique datasets and sector intelligence that reveal overlooked assets, emerging capabilities, and strategic whitespace across the pharmaceutical ecosystem.
We move beyond analysis — partnering with clients from opportunity discovery to transaction execution and strategic expansion.
Our areas of expertise
Deep expertise across the Life Sciences ecosystem.
Industries We Serve
Value chain coverage
Transaction Types
Selected experiences
Representative engagements supporting investors and operators across life sciences strategy and transactions.
Identified and prioritized acquisition targets in API manufacturing across North America and Europe, supporting a strategic client’s expansion strategy in high-growth CDMO segments.
Advised an investor on identifying platform acquisition opportunities in the pharmaceutical services ecosystem.
Conducted in-depth analysis of niche pharmaceutical services markets — including competitive landscape, service capabilities, industry trends, and strategic positioning — supporting expansion strategy for a U.S.-based pharma services company.
Developed a comprehensive market intelligence assessment of advanced therapies manufacturing capabilities across North America and Europe, supporting strategic investment evaluation in emerging CDMO segments.
Supported the evaluation of acquisition opportunities in sterile fill-finish manufacturing including target screening, strategic fit analysis, and transaction preparation.
Evaluated market dynamics, competitive positioning, and partnership opportunities to support expansion strategy for a specialty pharmaceutical company entering new therapeutic markets
Advised on the evaluation and structuring of a strategic partnership between a specialty pharmaceutical company and a commercial-stage biotech to support product commercialization.
Supported strategic evaluation & positioning of a pharmaceutical services business in preparation for a potential divestiture process, including market positioning and buyer universe analysis.
Who we work with
Tulevik supports investors, strategics, and innovators across the global life sciences ecosystem.
Private equity and growth investors seeking proprietary deal intelligence, platform investment strategies, and transaction support.
Companies and investors pursuing acquisitions, strategic partnerships, and growth in complex pharmaceutical services markets.
Companies evaluating acquisitions, partnerships, and strategic expansion opportunities.
Innovators navigating commercialization strategy, partnerships, and market entry.